Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation

被引:57
作者
Blouin, Stephane [1 ]
Fratzl-Zelman, Nadja [1 ]
Glorieux, Francis H.
Roschger, Paul [1 ]
Klaushofer, Klaus [1 ]
Marini, Joan C. [2 ]
Rauch, Frank [3 ]
机构
[1] Hanusch Hosp, Ludwig Boltzmann Inst Osteol, WGKK & AUVA Trauma Ctr, Med Dept 1, Vienna, Austria
[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD USA
[3] Shriners Hosp Children, Montreal, PQ, Canada
关键词
OSTEOGENESIS IMPERFECTA TYPE V; QUANTITATIVE BACKSCATTERED ELECTRON IMAGING; MATRIX MINERALIZATION; OSTEOCYTE LACUNAE; BISPHOSPHONATE TREATMENT; MINERALIZATION DENSITY; IFITM5; MUTATION; PHENOTYPIC VARIABILITY; HYPERPLASTIC CALLUS; COLLAGEN MUTATIONS; CHILDREN; ADOLESCENTS; PAMIDRONATE; BIOPSIES; GENOTYPE;
D O I
10.1002/jbmr.3180
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In co ntrast to "classical" forms of osteogenesis imperfecta (OI) types I to IV, caused by a mutation in COL1A1/A2, OI type V is due to a gain-of-function mutation in the IFITM5 gene, encoding the interferon-induced transmembrane protein 5, or bone-restricted interferon-inducible transmembrane (IFITM)-like protein (BRIL). Its phenotype distinctly differs from OI types I to IV by absence of blue sclerae and dentinogenesis imperfecta, by the occurrence of ossification disorders such as hyperplastic callus and forearm interosseous membrane ossification. Little is known about the impact of the mutation on bone tissue/material level in untreated and bisphosphonate-treated patients. Therefore, investigations of transiliac bone biopsy samples from a cohort of OI type V children (n = 15, 8.7 +/- 4 years old) untreated at baseline and a subset (n = 8) after pamidronate treatment (2.6 years in average) were performed. Quantitative backscattered electron imaging (qBEI) was used to determine bone mineralization density distribution (BMDD) as well as osteocyte lacunar density. The BMDD of type V OI bone was distinctly shifted toward a higher degree of mineralization. The most frequently occurring calcium concentration (CaPeak) in cortical (Ct) and cancellous (Cn) bone was markedly increased (+11.5%, +10.4%, respectively, p<0.0001) compared to healthy reference values. Treatment with pamidronate resulted in only a slight enhancement of mineralization. The osteocyte lacunar density derived from sectioned bone area was elevated in OI type V Ct and Cn bone (+171%, p<0.0001; +183.3%, p<0.01; respectively) versus controls. The high osteocyte density was associated with an overall immature primary bone structure ("mesh-like") as visualized by polarized light microscopy. In summary, the bone material from OI type V patients is hypermineralized, similar to other forms of OI. The elevated osteocyte lacunar density in connection with lack of regular bone lamellation points to an exuberant primary bone formation and an alteration of the bone remodeling process in OI type V. (C) 2017 American Society for Bone and Mineral Research.
引用
收藏
页码:1884 / 1892
页数:9
相关论文
共 51 条
[41]   Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies [J].
Roschger, P ;
Fratzl, P ;
Eschberger, J ;
Klaushofer, K .
BONE, 1998, 23 (04) :319-326
[42]   Bone mineralization density distribution in health and disease [J].
Roschger, P. ;
Paschalis, E. P. ;
Fratzl, P. ;
Klaushofer, K. .
BONE, 2008, 42 (03) :456-466
[43]   Constant mineralization density distribution in cancellous human bone [J].
Roschger, P ;
Gupta, HS ;
Berzanovich, A ;
Ittner, G ;
Dempster, DW ;
Fratzl, P ;
Cosman, F ;
Parisien, M ;
Lindsay, R ;
Nieves, JW ;
Klaushofer, K .
BONE, 2003, 32 (03) :316-323
[44]   Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations [J].
Roschger, Paul ;
Fratzl-Zelman, Nadja ;
Misof, Barbara M. ;
Glorieux, Francis H. ;
Klaushofer, Klaus ;
Rauch, Frank .
CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (04) :263-270
[45]   NIH Image to ImageJ: 25 years of image analysis [J].
Schneider, Caroline A. ;
Rasband, Wayne S. ;
Eliceiri, Kevin W. .
NATURE METHODS, 2012, 9 (07) :671-675
[46]   A Mutation in the 5′-UTR of IFITM5 Creates an In-Frame Start Codon and Causes Autosomal-Dominant Osteogenesis Imperfecta Type V with Hyperplastic Callus [J].
Semler, Oliver ;
Garbes, Lutz ;
Keupp, Katharina ;
Swan, Daniel ;
Zimmermann, Katharina ;
Becker, Jutta ;
Iden, Sandra ;
Wirth, Brunhilde ;
Eysel, Peer ;
Koerber, Friederike ;
Schoenau, Eckhard ;
Bohlander, Stefan K. ;
Wollnik, Bernd ;
Netzer, Christian .
AMERICAN JOURNAL OF HUMAN GENETICS, 2012, 91 (02) :349-357
[47]   Phenotypic Variability of Osteogenesis Imperfecta Type V Caused by an IFITM5 Mutation [J].
Shapiro, Jay R. ;
Lietman, Caressa ;
Grover, Monica ;
Lu, James T. ;
Nagamani, Sandesh C. S. ;
Dawson, Brian C. ;
Baldridge, Dustin M. ;
Bainbridge, Matthew N. ;
Cohn, Dan H. ;
Blazo, Maria ;
Roberts, Timothy T. ;
Brennen, Feng-Shu ;
Wu, Yimei ;
Gibbs, Richard A. ;
Melvin, Pamela ;
Campeau, Philippe M. ;
Lee, Brendan H. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (07) :1523-1530
[48]   GENETIC-HETEROGENEITY IN OSTEOGENESIS IMPERFECTA [J].
SILLENCE, DO ;
SENN, A ;
DANKS, DM .
JOURNAL OF MEDICAL GENETICS, 1979, 16 (02) :101-116
[49]   Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice [J].
Vanleene, Maximilien ;
Porter, Alexandra ;
Guillot, Pascale-Valerie ;
Boyde, Alan ;
Oyen, Michelle ;
Shefelbine, Sandra .
BONE, 2012, 50 (06) :1317-1323
[50]   Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta [J].
Weber, Markus ;
Roschger, Paul ;
Fratzl-Zelman, Nadja ;
Schoeberl, Thomas ;
Rauch, Frank ;
Glorieux, Francis H. ;
Fratzl, Peter ;
Klaushofer, Klaus .
BONE, 2006, 39 (03) :616-622